Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olr1323 Inhibitors

Olr1323 inhibitors are a specialized class of chemical compounds designed to target and inhibit the function of the Olr1323 receptor, an olfactory receptor that is part of the G protein-coupled receptor (GPCR) superfamily. These receptors are critical in the olfactory system, where they are responsible for detecting and interpreting a variety of odorant molecules, leading to the perception of smell. Olr1323 inhibitors function by binding to specific sites on the receptor, such as the active site where natural ligands would normally bind, or to allosteric sites that can modulate the receptor's activity. This binding prevents the receptor from undergoing the necessary conformational changes that are essential for activating intracellular signaling pathways. As a result, the inhibitors block the receptor's ability to transmit olfactory signals, effectively disrupting the normal functioning of the olfactory system. The design and development of these inhibitors often rely on detailed structural studies of the Olr1323 receptor, utilizing advanced techniques like X-ray crystallography, molecular modeling, and cryo-electron microscopy. These structural insights are crucial for designing inhibitors that are highly specific to the Olr1323 receptor and capable of modulating its activity with precision.

Chemically, Olr1323 inhibitors display a broad range of molecular structures, reflecting the different strategies employed in their synthesis. These inhibitors may be small, lipophilic molecules that can easily cross cellular membranes to reach their target receptors, or they may be larger, more complex structures that require sophisticated synthetic methods to achieve optimal binding affinity and specificity. The synthesis of Olr1323 inhibitors typically involves multiple steps of organic chemistry, including the construction of molecular frameworks and the incorporation of functional groups that enhance binding interactions with the receptor. Once synthesized, these compounds undergo rigorous characterization using a variety of analytical techniques, such as nuclear magnetic resonance (NMR) spectroscopy, mass spectrometry, and high-performance liquid chromatography (HPLC). These methods are used to confirm the structural integrity, purity, and inhibitory potency of the compounds. The study of Olr1323 inhibitors is important for advancing our understanding of the specific mechanisms by which this olfactory receptor operates and how its activity can be modulated by small molecules. Additionally, this research contributes to the broader field of GPCR modulation, offering valuable insights into the molecular processes underlying sensory perception, particularly in the context of olfaction. By deepening our knowledge of how olfactory receptors function and how they can be selectively targeted, scientists can explore new directions in the study of sensory systems and the complex biochemical pathways that govern them.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

Proteasome inhibitor, potentially affecting protein degradation pathways relevant to Olr1323.

XL-184 free base

849217-68-1sc-364657
sc-364657A
5 mg
10 mg
$94.00
$208.00
1
(1)

Inhibits MET, VEGFR, and AXL kinases, might disrupt cell signaling pathways impacting Olr1323.

Dasatinib

302962-49-8sc-358114
sc-358114A
25 mg
1 g
$70.00
$145.00
51
(1)

Src family kinase inhibitor, potentially altering cell proliferation and survival pathways affecting Olr1323.

Erlotinib Hydrochloride

183319-69-9sc-202154
sc-202154A
10 mg
25 mg
$75.00
$121.00
33
(1)

EGFR tyrosine kinase inhibitor, might disrupt signaling pathways that influence Olr1323 activity.

Ibrutinib

936563-96-1sc-483194
10 mg
$156.00
5
(0)

Bruton's tyrosine kinase inhibitor, could affect immune signaling pathways relevant to Olr1323.

Lapatinib

231277-92-2sc-353658
100 mg
$420.00
32
(1)

Dual EGFR and HER2 inhibitor, potentially modulating signaling pathways relevant to Olr1323's function.

Nilotinib

641571-10-0sc-202245
sc-202245A
10 mg
25 mg
$209.00
$413.00
9
(1)

BCR-ABL kinase inhibitor, might impact cell proliferation and survival pathways influencing Olr1323.

Palbociclib

571190-30-2sc-507366
50 mg
$321.00
(0)

CDK4/6 inhibitor, could modulate cell cycle regulation pathways impacting Olr1323.

Pazopanib

444731-52-6sc-396318
sc-396318A
25 mg
50 mg
$130.00
$182.00
2
(1)

Inhibits multiple tyrosine kinases, potentially affecting pathways influencing Olr1323, like angiogenesis or cell proliferation.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$57.00
$100.00
$250.00
129
(3)

Multi-kinase inhibitor, might disrupt several signaling pathways involving Olr1323.